historyOfBreast-conservingSurgery
mayUsed
metastaticDiseaseOnPresentation
strongContrastWithImagingModalities
formulation
femaleSibling
patientsWithLabc
brca1Wild-typeTnbcCells
results
themselves
greater
effectiveDiagnosisOfBreastCancer
fiveDoses
modifiedFactor
strongIndependentPrognosticFactor
screening
patients
humanErrors
developed
presenceOfMetastaticDiseaseAtPresentation
familyHistory
established
mostSensitiveTestForBreastCancerDetection
complex
strongFamilyHistoryOfCancer
measured
23Studies
additionalIndicator
visuallyDetectable
accomplished
diagnosticPerformanceOfCxcr4-directedPetImagingInPatientsWithBreastCancer
lungCancerInHuman
at25HPost-injectionGreaterInTumorBedThanInKidneyRespectively
ourExperience
familyImpact
387Percecnt
veryComplexDisease
previousStudies
meta-analysis
malign
lowDiagnosticSensitivityForWomenWithDenseBreasts
therapeuticApproachesEspeciallyUnderViewOfCurrentDevelopments
amount
chestWallLesions
secondaryConfirmationOfSignalAccumulationUsingNearInfraredFluorescentImaging
infraredFluorescentImagingInTripleNegativeInVitro
variableMolecularMechanismsOfCarcinogenesis
performance
theirBeliefsRegardingCancerCausation
givenRecentConcernsAboutGadolinium-basedContrastAgentsAreAlsoInvestigatedForBreastCancerDiagnosis
test
correspondingCohort
brca1Levels
cancer
abbreviatedMriProtocols
mostCommonCancer
second
hasFound
diet
fiveDosesOfAdjuvantTranstuzumab
howeverUnderutilized
glycosylationOfMembraneTypeMr
therapeuticBenefits
triple-negativeBreastCancers
enhancementOfImage
recognized
cxcr4ExpressionDeterminedByImmunohistochemistry
potential
outcomeOverCosts
recorded
theirOriginallyTargetedPopulationsOfBreastCancer
tnbcCells
issuesOfExistingContrastAgents
apoptosis
agents
breastCancerDiagnosis
implemented
associationBetweenPost-diagnosisLow-doseAspirinUse
associationBetweenIntakeOfB-carotene
recentlyIntroducedCxcr4-targetedPetProbe68ga-pentixafor
analyzed
feasibleInProperlySelectedCasesWithAsymptomaticNeuromasAfterAccurateTissueSampling
specificCancerCell-relatedComponents
imaging
issues
additionalAnti-her2Therapy
outcomesOfEstrogenReceptorPositive
invasiveBreastCancer
detectionOfBreastCancerInWomen
NAC
found
furthermoreDiagnosedWithPaAtEarlierAgeThanPatientsWithNegativeFamilyHistory
brcanessPhenotypeInBrca1Wild-typeTnbcCells
protected
multipleFactors
differentContrastAgent
widerPopulationOfTnbcPatients
updateOnRiskFactorsForSeromaProductionAfterBreastCancerSurgery
theirExperiencesLivingWithSister
previousBreast/axillarySurgery
veryRareClinicalEntityWithOnlyFewCasesHavingReportedToDate
images
randomEffectsModel
familyMember
familyMemberAffectedWithCancer
life
henceCurrentlyOnlyRoutinelyImplementedInScreeningOfWomenAtIncreasedRiskOfBreastCancer
neuralNetworkClassifier
total
women
evidencedByIncreaseInContrastAfterInjection
comparedSemi-quantitatively
mustAddressed
asResultAreUsed
estimated
dnaDamage
responsible
brca1Wild-typeTripleNegativeBreastCancer
brd4Regulation
cellCycleRegulators
IORT
betterOutcomeWithGoodNegativePredictiveValue
alsoShaped
treatment
due
useOfAdvancedImagingExaminations
evaluatedInVivo
allFiveCases
managementOfTumour-relatedSymptoms
summaryHazardRatioOf070ForHighestIntake
825Ml
radiotherapy
intravenousAdministrationOfOsteopontin-750Probe
formulationOfEffectiveManagementPlanForAt-riskWomen
understand
18f-fdgPet
haveDeveloped
notablyDesigned
haveValidatedByClinicalStudiesInCardiotoxicityDiagnosisInPatientsTreatedWithHighDosesOfAnthracyclinesAloneInCombinationMainlyWithTrastuzumab
breastCancers
performed
consistent
rare
mostInvasiveDisease
25Months
sensitive
amongThemNewlyIdentifiedInStudy
majorConcerns
subtype-specificPrognosticSignatures
diagnosisOfResponseToTreatment
diagnosed
breastTumor
highlyExpressed
largeCohortOfPatientsWithPituitaryAdenomasInOutpatientClinic
case
seromaProduction
largelyConsistent
nudeMice
60Years
misdiagnosis
differentialDiagnosisInPatientsWithHistoryOfBreastSurgery
involvedInDnaDamageRegulation
CBC
included
combinationsOfInductionInBrca1Wild-typeTripleNegativeBreastCancer
preciseToolForTargetedTreatmentOfCancerIncludingBc
firstDiagnosisOfBreastCancer
patientsWithProlactinoma
particular
familialCancerClusteringInPatientsWithProlactinoma
time-varyingPost-diagnosisLow-doseAspirinUse
thanFamiliesOfPatientsWithNon-functioningPituitaryAdenomas
20PercecntIncreasedRiskOfBreastCancerAmongCurrentHormonalContraceptionUsers
PA
areUsed
overviewOfAbbreviatedBreastMriProtocols
unusual
performedFromInceptionToJanuary312018
discussed
missed
breastCancerPatientsSerum
patient'sOutcomeOverCosts
patientsWithBreastCancerReceivingWithAnthracyclines
riskStratification
aspirinUse
non-ideal
denseBreasts
only35CasesOfTraumaticBreastNeuromas
haveReportedMainlyAfterMastectomy
associationBetweenPost-diagnosisUseOfLow-doseAspirin
needed
used
newValue-basedHealthcareParadigm
areInvestigated
x-rayMammography
itsWidespreadUse
mayIndicativeOfBenignLesion
stageIiiBreastCaner
required
inLongTermHasFound
present
unresectedLocallyAdvancedBreastCancer
glycosylation
bindingToBreastCancerCellsInVitro
human
itsUse
elderlyPatientWithRelapsedHer2
oneYearOfDiseaseControlWithoutDeteriorationInHerEjectionFraction
reported
haveReported
moreDirectional
limitedEvidenceForSignificantlyInverseAssociationBetweenPrediagnosisDietaryIntakeOfB-caroteneAmongWomenWithBreastCancer
applied
inConclusionStillNecessaryForAdoptionOfCtnAsRoutineClinicalBiomarkerInPatientsWithBreastCancer
breastCancer
harmfulorHarmlessTissues
imagingModalities
ourExperienceOfHigh-doseRadiotherapy
selectiveAccumulationOfFluorescentOsteopontinInVitroAndInVivo
68Ga-Pentixafor
potentialOfAionAsEffectiveMultimodalContrastAgentForBreastCancerDiagnosis
56Percecnt
BRCA1
necessity
feasible
shaped
combination
soFarHasMainlyAssociatedWithMutationsInBrca1
indicator
mutationalStatusBesidesFamilyHistory
thematicAnalysis
primaryBreastCancerPatientsTreatedBetween01012010
ageOf25Years
fourTypesOfBreastCancer
hasApplied
nationwideRegistries
MSOT
amountOfObservedVariationInSeromaProduction
diagnosisOfAcuteCoronarySyndromes
relativesOfPatientsWithPa
patient
trendForLessRadicalSurgicalApproachesInBreastCancerDueBetterUnderstandingOfTumourBiology
confirmed
risk
theirAbilityOfPrognosisPredictionInTheirOriginallyTargetedPopulationsOfBreastCancer
mostSensitiveTest
value
signatures
significantlyHigherThanInFamiliesOfNfpaPatients
375Percecnt
related
outpatientClinic
sixGlycosylationSites
concerns
formedByCo-encapsulationOfNear-infraredFluorophoreInPegylatedMicelles
necessary
increasedRiskWithUseOfLevonorgestrelIntrauterineSystem-bothOfPotentiallyImportantFindings
howeverNon-ideal
urgentlyNeeded
higher
transferable
targetedImmuneCell
advancedDiagnosticImaging
expressed
mriProtocols
osteopontinPeptide
imagingInvestigations
patientsWithHistoryOfBreastSurgery
patientsWithHistoryOfTranstuzumab-inducedCardiacDysfunction
infraredFluorescentDye
haveIntroduced
tumorImaging
woundDrainsPlacedInBreast
massSpectrometry
identified
diagnosis
inconsistentResults
54Percecnt
lapatinibCombined
generallyReserved
mostEffectiveTechniqueused
similar
overview
thereforeHasAppliedToEarlyIdentification
factor
veryRareCaseOfTraumaticBreastNeuroma
oneYear
mayUsedForTumourShrinkagePriorToSurgery
developedCbcDuring
course
hasInconsistent
stratified
heterogeneousCancerInFemalePatientsWorldwide
use
binding
update
costOfMriExamination
involved
thusWouldCrucialForApplicationOfPreventiveStrategies
moreRecentlyHaveDeveloped
mustAddressedDuringCancerGeneticCounselingConsultations
reduction
decreasesInBcMortalityRates
dose-dependentReductionInBrca1Levels
preclinicalPhase
currentUsersOfLongerDuration
neoadjuvantAnti-her2Treatment
contrastAfterInjection
compared
howeverSignificantlyLower
reportedInSignificantlyHigherProportionOfPatientsWithPa
strong
processing
moreCommonlyDiagnosed
aggressiveCourseOfHer2Cancer
bcMortalityRates
brcanessPhenotype
decades
management
high-resolutionImages
designed
only35Cases
copyright
itsMinimalSilverIonReleaseProfiles
25MonthsFromDiagnosis
mostCommonAgentsUsedInBreastCancerTreatment